| SKŘIČKOVÁ, Jana, Karel HEJDUK, Zbyněk BORTLÍČEK, Marcela TOMÍŠKOVÁ, Monika ŠATÁNKOVÁ a Ilona BINKOVÁ. Gefitinib in first-line treatment of caucasian patients with NSCLC and EGFR Mutations in Exons 19 or 21. Online. In IASLC 17th world conference on Lung Cancer, vienna, Rakousko. 2016, [citováno 2024-04-23] |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1371790,
author = {Skřičková, Jana and Hejduk, Karel and Bortlíček, Zbyněk and Tomíšková, Marcela and Šatánková, Monika and Binková, Ilona},
booktitle = {IASLC 17th world conference on Lung Cancer, vienna, Rakousko},
title = {Gefitinib in first-line treatment of caucasian patients with NSCLC and EGFR Mutations in Exons 19 or 21},
year = {2016}
}
TY - CONF
ID - 1371790
AU - Skřičková, Jana - Hejduk, Karel - Bortlíček, Zbyněk - Tomíšková, Marcela - Šatánková, Monika - Binková, Ilona
PY - 2016
TI - Gefitinib in first-line treatment of caucasian patients with NSCLC and EGFR Mutations in Exons 19 or 21
ER -
SKŘIČKOVÁ, Jana, Karel HEJDUK, Zbyněk BORTLÍČEK, Marcela TOMÍŠKOVÁ, Monika ŠATÁNKOVÁ a Ilona BINKOVÁ. Gefitinib in first-line treatment of caucasian patients with NSCLC and EGFR Mutations in Exons 19 or 21. Online. In \textit{IASLC 17th world conference on Lung Cancer, vienna, Rakousko}. 2016, [citováno 2024-04-23]
|
